Mitogen-activated Protein Kinase Signalling and ERK1/2 Bistability in Asthma
Overview
Authors
Affiliations
Mitogen-activated protein kinases (MAPKs) integrate signals from numerous receptors and translate these signals into cell functions. MAPKs are critical for immune cell metabolism, migration, production of pro-inflammatory mediators, survival and differentiation. We provide a concise review of the involvement of MAPK in important cells of the immune system. Certain cell functions, e.g. production of pro-inflammatory mediators resolve quickly and may require a transient MAPK activation, other processes such as cell differentiation and long-term survival may require persistent MAPK signal. The persistent MAPK signal is frequently a consequence of positive feedback loops or double negative feedback loops which perpetuate the signal after removal of an external cell stimulus. This self-perpetuated activation of a signalling circuit is a manifestation of its bistability. Bistable systems can exist in 'on' and 'off' states and both states are stable. We have demonstrated the existence of self-perpetuated activation mechanism for ERK1/2 in bronchial epithelial cells. This sustained activation of ERK1/2 supports long-term survival of these cells and primes them for cytokine transcription. ERK1/2 bistability arises from repetitive stimulation of the cell. The repeated stimulation (e.g. repeated viral infection or repeated allergen exposure) seems to be a common theme in asthma and other chronic illnesses. We thus hypothesize that the self-perpetuated ERK1/2 signal plays an important role in the pathogenesis of asthma.
Abulaiti K, Aikepa M, Ainaidu M, Wang J, Yizibula M, Aikemu M Chin Herb Med. 2024; 16(4):599-611.
PMID: 39606263 PMC: 11589474. DOI: 10.1016/j.chmed.2024.02.001.
Kim S, Um Y, Chung S, Jeong K, Park H, Park K World Allergy Organ J. 2024; 17(9):100956.
PMID: 39262899 PMC: 11388501. DOI: 10.1016/j.waojou.2024.100956.
Tang D, Wang C, Liu H, Wu J, Tan L, Liu S Int J Mol Sci. 2024; 25(16).
PMID: 39201796 PMC: 11354367. DOI: 10.3390/ijms25169110.
Mallek N, Martin E, Dailey L, McCullough S Front Toxicol. 2024; 5:1264331.
PMID: 38464699 PMC: 10922929. DOI: 10.3389/ftox.2023.1264331.
miRNAs as Modern Biomarkers in Asthma Therapy.
Kierbiedz-Guzik N, Sozanska B Int J Mol Sci. 2023; 24(14).
PMID: 37511254 PMC: 10380449. DOI: 10.3390/ijms241411499.